Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2011 (2011), Article ID 686924, 6 pages
Clinical Study

Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study

1Division of Psychiatry, Haukeland University Hospital, Sandviksleitet 1, 5035 Bergen, Norway
2Department of Clinical Medicine, Psychiatry, University of Bergen, Sandviksleitet 1, 5035 Bergen, Norway
3Institute Biological and Medical Psychology, University of Bergen, Sandviksleitet 1, 5035 Bergen, Norway

Received 25 June 2011; Accepted 14 September 2011

Academic Editor: Hussein Ghanem

Copyright © 2011 Erik Johnsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Introduction. Sexual dysfunction (SD) and hyperprolactinemia are frequently reported in patients with psychotic disorders and have the potential for severe complications but investigations in males are particularly scarce. The primary aims were to determine the prevalence of SD and hyperprolactinemia in male patients and to investigate whether associations exist between SD and prolactin levels. Methods. Cross-sectional data were obtained at discharge from the hospital or 6 weeks after admittance for patients acutely admitted for psychosis and treated with a second-generation antipsychotic drug. Results. Half the patients reported diminished sexual desire and more than a third reported erectile and ejaculatory dysfunctions with no differences among the drugs. More than half the sample was hyperprolactinemic. No association was found between prolactin levels and SD. Conclusion. High rates of SD and hyperprolactinemia were found in male patients and should be a treatment target. SD and hyperprolactinemia were not correlated.